Objective: The objective of this study was to estimate the proportion of pregnant women with systemic lupus erythematosus meeting Institute of Medicine guidelines for gestational weight gain and determine correlates of adherence to guidelines. Methods: Singleton, live births in the Hopkins Lupus Pregnancy Cohort 1987-2015 were included. Pre-pregnancy weight was the weight recorded 12 months prior to pregnancy/first trimester. Final weight was the last weight recorded in the third trimester. Adherence to Institute of Medicine guidelines (inadequate, adequate, or excessive) was based on pre-pregnancy body mass index. Fisher's exact test and analysis of variance determined factors associated with not meeting guidelines. Stepwise selection estimated predictors of gestational weight gain. Results: Of the 211 pregnancies, 34%, 24% and 42% had inadequate, adequate and excessive gestational weight gain, respectively. In exploratory analyses, differences in Institute of Medicine adherence were observed by prepregnancy body mass index, race, elevated creatinine during pregnancy and pre-pregnancy blood pressure. Odds of inadequate and excessive gestational weight gain increased 12% with each 1 kg/m 2 increase in pre-pregnancy body mass index. Lower maternal education was associated with increased odds of inadequate and excessive gestational weight gain. Conclusions: As in the general population, most women with systemic lupus erythematosus did not meet Institute of Medicine guidelines. Our results identified predictors of gestational weight gain to aid in targeted interventions to improve guideline adherence in this population. Lupus (2017) 26, 623-632.
Background
In 1990, the Institute of Medicine (IOM) published guidelines for ideal weight gain during pregnancy based on pre-pregnancy body mass index (BMI). These guidelines were updated in 2009, due in part to the concern about rising obesity rates in the population. 1 Although the 2009 committee was not intended to develop gestational weight gain (GWG) guidelines for specific diseases or conditions, a noticeable gap in the literature was the availability of data on the weight gain patterns in patients with autoimmune diseases. Of particular interest was systemic lupus erythematosus (SLE), a disorder that largely affects women between the ages of 15 and 44 years. 2 It is not presently known if women with SLE are gaining the appropriate amount of weight and what factors may affect weight gain in these women.
GWG is the amount of weight a mother gains throughout her pregnancy and is composed of maternal and fetal products of conception. The average weight gain attributable to fetal components is 4.8 kg, consisting of the fetus (3.3 kg), the placenta (0.7 kg) and amniotic fluid (0.8 kg). For maternal components, the average weight gained is 7 kg, largely due to increase in fat (4.0 kg), blood volume (1.2 kg) and extracellular fluid (1.2 kg). 3 The pattern of weight gain during pregnancy varies greatly among women. One study found the average weekly weight gain for the second and third trimesters was higher for underweight and normal weight women compared to overweight and obese women. In addition, in this study, all women except obese women had higher weekly rates of weight gain in the second trimester than in the third trimester. 4 The appropriate amount of weight gained during pregnancy has great implications for the infant: gaining too much weight during pregnancy has been shown to be associated with delivering large for gestational age (LGA) or macrosomic (>4000 g) infants, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] while insufficient weight gain is associated with the delivery of a small for gestational age (SGA) infant. 6, 7, [10] [11] [12] [13] [14] [15] [16] 22 GWG also has implications for preterm birth. There appears to be a U-shaped association of GWG with preterm birth, with modification by pre-pregnancy BMI. [23] [24] [25] [26] [27] Among women who are underweight according to their pre-pregnancy BMI, insufficient GWG is associated with an increased risk of preterm birth, and this association weakens as pre-pregnancy BMI increases. Excessive GWG may be associated with preterm birth in women of all pre-pregnancy BMI categories. 27, 28 The vast majority of women in the general population do not meet the IOM guidelines for weight gain, with one study finding that 17% had inadequate weight gain, 31% had adequate weight gain and 53% of mothers had excessive weight gain. 29 Women classified as overweight or obese were at increased risk of gaining more than the recommended amount of weight during pregnancy, compared to women with normal BMI. Unfortunately, the proportion of women who are exceeding the guidelines for GWG is increasing, 29 which is why the IOM committee has called for a paradigm shift in how preconception and prenatal advice concerning weight gain is being delivered to women of childbearing ages. The objectives of this study were to estimate the proportion of women with SLE who meet the IOM guidelines for GWG and to determine correlates of adherence to IOM guidelines for GWG.
Methods

Study population
The Hopkins Lupus Pregnancy Cohort is a subset of the Hopkins Lupus Cohort, which has prospectively followed patients with SLE since 1987, with data available to 6 February 2015 (n ¼ 515 33 Pregnant women were seen every 4-6 weeks throughout their pregnancy at the Lupus Center in Baltimore, Maryland by a single rheumatologist (average 5.3 weeks). During each visit, a patient's weight was recorded, lupus disease activity was determined by the physician global assessment (PGA) of disease activity, medications were updated and laboratory tests were conducted. Laboratory tests included complete blood count, complement levels, autoantibodies and urinalysis.
Gestational weight gain
The outcome of interest was the proportion of women with SLE who met the 2009 IOM guidelines for GWG based on pre-pregnancy BMI. Prepregnancy weight was defined as the most recent weight recorded at a visit within 12 months prior to pregnancy (average weeks prior to pregnancy 8.4 weeks, standard deviation (SD) 1.9) or, if not available, in the first trimester (n ¼ 64, average gestational age 8.4 weeks, SD 3.2). The final pregnancy weight was the weight recorded closest to birth in the third trimester (average gestational age 34.8 weeks, SD 2.9). Observed weight gain was calculated as the difference in the first and final weight measurements. The estimated total weight gain was calculated to account for variations in the timing of the first and final weight: (observed weight gain/ weeks of gestation between weight measurements) Â 40 weeks.
The estimated total weight gain was classified according to IOM guidelines based on a woman's pre-pregnancy BMI: underweight (<18. 5 Total weight gain below the recommendations is considered inadequate weight gain, and total weight gain above the recommendations is considered excessive weight gain.
Covariates
Population characteristics of interest included selfreported race (black vs. non-black), education, age at conception and duration of SLE. Infant birth date (categorized as prior to January 1999 or between January 1999 and February 2015) was considered a variable of interest due to changes in SLE prescribing patterns and general population shifts in BMI over time. Information on medication SLE treatment used during pregnancy included: anti-malarial, immunosuppressants, prednisone and prednisone 15 mg/day or greater. Clinical characteristics and biomarkers of SLE recorded as ever occurring during pregnancy were: renal involvement (renal lupus activity index > 1), elevated serum creatinine (>1 mg/dL), high PGA (!2), low complement (C3 and C4), and anti-double-stranded DNA (ever positive). Maternal cumulative organ system damage at conception was measured by the SLICC/ACR index (SDI), with a score of 1 or more representing the presence of any organ system damage. Pre-pregnancy blood pressure on the study visit closest to conception in the one year prior to pregnancy or first trimester was classified according to American Heart Association (AHA) criteria for cardiovascular health: poor/intermediate blood pressure: systolic ! 120 or diastolic ! 80 mmHg or treated to goal; ideal health: <120 and < 80 mmHg without treatment. 34 Pre-pregnancy total cholesterol on the study visit closest to conception in the one year prior to pregnancy or first trimester was classified according to AHA criteria for cardiovascular health: poor/intermediate total cholesterol: !200 mg/dL or treated to goal; ideal health: <200 mg/dL without treatment. 34 Pregnancy outcomes of interest included gestational age at birth and birth weight for gestational age z-score. Gestational age at birth was based on maternally reported last menstrual period date and date of delivery, and categorized as preterm (<37 weeks) and term (!37 weeks), as well as analyzed as a continuous variable. Birth weight for gestational age z-score was based on US population reference percentiles of birth weight for singleton infants, stratified by infant sex. 35 Z-scores in Oken et al. (2003) 35 were calculated based on the distribution of birth weights for all live births born at 22 to 44 weeks gestation in the USA, 1999-2000, with a potential range of -2.58 to 2.58. Birth weight for gestational age z-score was analyzed as a continuous variable, as well as categorized based on the percentile of birth weight for gestational age: less than 10th percentile (SGA) and greater than 90th percentile (LGA).
Subject selection
During the study period, there were 515 pregnancies in the Hopkins Lupus Cohort, of which 431 were live births ( Figure 1 ). More than one singleton live birth per patient was allowed in the analysis. Pregnancies without a weight measurement in the one year prior to the last menstrual period prepregnancy or during the first trimester, and/or without a weight measurement in the third trimester, were excluded. Of the 431 live births, 291 pregnancies had a weight measurement during the one year prior to pregnancy or during the first trimester, and of these, 211 pregnancies had an additional weight measurement during the third trimester.
Analysis
Adherence to the IOM recommendations was classified as a categorical variable (inadequate, adequate or excessive weight gain) based on prepregnancy BMI. The percentage of women who had inadequate, adequate or excessive weight gain, based on their pre-pregnancy BMI group, was estimated, and the mean estimated total weight gain was calculated. An exploratory analysis determined factors associated with not meeting IOM guidelines by Fisher's exact test of differences in proportions and analysis of variance (ANOVA) compared differences in means. A generalized logit model analysis with stepwise selection determined predictors of inadequate and excessive weight gain, both compared to adequate weight gain. Generalized estimating equation methods were used to account for the potential correlation of multiple pregnancies per patient being included in the analysis. 36 Potential variables were entered into the model if a was less than 0.2 and remained in the model if a was less than 0.05. Covariates included in the model were race, education, infant delivery year, age at conception, duration of SLE, medication use ever during pregnancy (anti-malarial, immunosuppressants, prednisone and prednisone ! 15 mg/day), SDI at conception and clinical characteristics ever occurring during pregnancy (renal involvement, elevated serum creatinine, high PGA, low complement and anti-dsDNA).
Weight trajectories for GWG were estimated using mixed models. Mixed models include fixed and random effects and are ideal for repeated measures with a varying number of measurements and time between measurements per subject. 37 The model included a random effect for the intercept and for time (weeks of gestation). The fixed effects included a linear effect for time, quadratic effect for time, BMI group, and interaction for BMI group and time. All analyses were conducted with SAS 9.3 (Cary, NC, USA).
Results
There were 211 pregnancies among 182 women included in the analysis. The majority of women were white (59%), with a median age at pregnancy of 30 years and median disease duration of 5 years. Overall, 34% of women had inadequate weight gain, 24% had adequate weight gain and 42% had excessive weight gain (Figure 2 ). Differences were observed by pre-pregnancy BMI. Among underweight women, 67% of pregnancies had inadequate GWG and 33% had adequate GWG. Among normal weight women, pregnancies were fairly evenly divided, with 30%, 32% and 38% having inadequate, adequate and excessive weight gain, respectively. On the other hand, among overweight and obese women, few had inadequate GWG, 51% of both groups had excessive GWG and only 19% and 7% of overweight and obese women, respectively, gained within the recommended guidelines. There were nine pregnancies in which the mother lost weight, ranging from 1.5 kg to 16.0 kg; all had BMI in the range of overweight or obese. The mean (SD) estimated total weight gain was 10.9 (3.4) kg for underweight women, 14.7 (6.4) for normal weight women, 12.9 (8.8) for overweight women, and 8.3 (12.4) for obese women. In exploratory analyses, there were observed differences in adherence to IOM guidelines by race, elevated creatinine during pregnancy, pre-pregnancy blood pressure and pre-pregnancy BMI ( Table 1 ). The mean pre-pregnancy BMI for patients with inadequate, adequate and excessive weight gain was 26.9 kg, 23.4 kg, and 26.6 kg, respectively (P ¼ 0.004). Of interest, there were no differences in weight gain adherence to IOM guidelines by SLE medication use during pregnancy, and adherence to GWG guidelines did not appear to correlate with pregnancy outcomes.
In exploratory analyses, no differences in guideline adherence were observed for infants who were SGA compared to infants who were not SGA (P ¼ 0.2), for infants who were LGA compared to infants who were not LGA (P ¼ 0.8), or for infants who were preterm compared to term (P ¼ 0.6). The mean gestational age at birth (P ¼ 0.2) and birthweight percentile (P ¼ 0.07) were both similar across levels of guideline adherence.
In logistic regression models, stepwise selection determined continuous pre-pregnancy BMI and maternal education level were predictors of inadequate and excessive weight gain (Table 2) . With each 1 kg/m 2 increase in pre-pregnancy BMI, the odds of inadequate weight gain and excessive weight gain both increased 12%. Compared to patients with a greater than college education, patients with a high school education had approximately three times the odds of inadequate weight gain and twice the odds of excessive weight gain. Figure 3 illustrates the mean predicted change in maternal weight, stratified by pre-pregnancy BMI category (underweight/normal weight, overweight, and obese). Normal weight and underweight women were pooled into one category due to the small number of underweight women. The weight gain trajectory did not change in a sensitivity analysis removing underweight women from the analytic cohort. The weight gain trajectories in normal weight/underweight women and overweight women appear to be similar, with weight increasing steadily throughout pregnancy. The trajectories for obese women, however, were different from normal weight/underweight and overweight women, with a decrease in weight observed at the beginning of pregnancy.
Discussion
In this study of pregnant women with SLE, 34% of pregnancies had inadequate weight gain, 24% of pregnancies had adequate weight gain and 42% had excessive weight gain, rates similar to those observed in the general population of pregnant women in the United States. 38 In a recent analysis of the pregnancy risk assessment monitoring system (PRAMS) 2010-2011, 21%, 32% and 47% of women reported having inadequate weight gain, adequate weight gain, and excessive weight gain during pregnancy, respectively. 38 In PRAMS, underweight women and normal weight women had decreased odds versus excessive weight gain, while overweight and obese women had increased odds of excessive weight gain. 38, 39 Similar patterns were observed in our cohort of SLE women, with the frequency of excessive weight gain lower in normal weight and underweight women than overweight and obese women.
In exploratory analyses, some demographic and clinical characteristics were found to be associated with GWG, but in adjusted models, only pre-pregnancy BMI and maternal education were found to predict GWG. The demographic differences observed in our study, increased frequency of inadequate weight gain among black patients compared to non-black patients and increased frequency of inadequate weight gain among patients with a high school education compared to more than a college education, have also been reported in the general population. 38 In the general population, a previous study has reported that among normal weight women, there is an increased odds of excessive weight gain in patients with hypertensive conditions. 38 In our exploratory analysis, we also observed differences by pre-pregnancy blood pressure, with an increased frequency of both inadequate and excessive weight gain among patients with intermediate and poor pre-pregnancy blood pressure compared to patients with ideal pre-pregnancy blood pressure.
In exploratory analyses, a difference was observed in IOM guideline adherence for patients who had elevated creatinine during pregnancy compared to patients who did not. Although the number of patients with elevated creatinine was small (n ¼ 15), 53% of these patients had inadequate weight gain compared to 33% of patients 
without elevated creatinine, and 0% had adequate weight gain compared to 26% of patients without elevated creatinine. Elevated creatinine indicates renal insufficiency. 40 While we did not observe any differences in guideline adherence for patients with and without renal involvement during pregnancy, it appears that patients with elevated creatinine during pregnancy are at particular risk of not adhering to recommended guidelines, which may warrant further investigation.
Of particular interest was the lack of association of SLE medication use during pregnancy and GWG in exploratory analyses, including prednisone use or use of high prednisone dose (!15 mg/day). This is in contrast to what was expected, given that prednisone has been found to increase adipose tissue among users. 41 Only 21 of the 102 pregnancies with maternal exposure to prednisone initiated prednisone treatment during pregnancy. It may be that no increased frequency of excessive GWG with prednisone use was observed because patients have already experienced the increase in body mass associated with prednisone use, and no additional weight increases occurred during pregnancy.
Results from weight trajectory analyses suggest that the change in weight throughout pregnancy is similar for underweight, normal weight and overweight women, but varies for obese women. Among obese women, weight appears to decrease during the first trimester and then increase at the start of the second trimester. This is of interest, as weight measurements for women in this study were based on clinic measurements rather than self-report. Therefore, the weight fluctuations suggest a true initial decrease in weight and variability in weight gain among obese women, rather than an observed bias due to inaccurate reporting of prepregnancy weight that may occur with self-reported weights. Previous research has found that factors associated with non-adherence, such as race, education and certain co-morbidities vary by BMI group. 38 A limitation of the present analysis is that the sample size of 211 women did not provide sufficient power to analyze interactive effects of BMI with demographic and clinical factors. Such analyses of interactive effects may help provide additional clarity on the unexpected results of no difference in guideline adherence by maternal prednisone use during pregnancy, which we were unable to discern due to the limited sample size. In addition, the estimated due date was calculated for each patient based on the last menstrual period, rather than early ultrasound, which may have miscalculated the correct estimated due date by 1-2 weeks. Finally, data were unavailable on patients' physical activity and diet, which may help further explain differences in weight gain patterns in this population.
Despite these limitations, our study was strengthened by the prospective collection of clinically recorded weights, rather than relying on selfreport of pre-pregnancy weight of total GWG by the patient, which has been found often to be inaccurately remembered at the time of delivery. 42 In addition, the present analysis benefits from weights being measured at multiple times during pregnancy, with a median of four visits per patient, which allowed for weight gain trajectories to be constructed. Although the sample size is modest, this study reports one of the largest cohorts of pregnant women with SLE, and it is the first study to analyze GWG patterns in SLE.
The results of this analysis show that the majority of women with SLE do not meet the IOM guidelines for GWG. Pre-pregnancy BMI was found to be associated with not meeting guidelines in this study population, which is similar to what is observed in the general population. Targeted interventions to increase patient awareness about GWG guidelines and improve BMI prior to women with SLE becoming pregnant are important next steps for rheumatologists and obstetricians treating SLE patients to adopt in order to improve guideline adherence. Given that women with SLE are encouraged to seek pre-conception counselling with their physician to ensure that disease activity is properly controlled and medications being taken are safe during pregnancy, this preconception visit would be an ideal time for a discussion about the IOM guidelines for weight gain and the implications of not adhering to the guidelines. In addition, as BMI was found to be an important predictor of non-adherence to weight gain guidelines in our study, this pre-conception visit would also provide the opportunity to discuss a patient's current BMI and encourage the patient to be within the normal BMI range prior to becoming pregnant.
It has yet to be determined if the IOM guidelines for weight gain in the general population are appropriate for women with SLE, and future studies are necessary to determine if pregnancy outcomes in women with SLE are improved when IOM guidelines for GWG are met. As research in the general population has shown that adherence to IOM guidelines has significant implications for the future health of both the mother and infant, it is important to understand further what factors may be associated with non-adherence to guidelines in women with SLE. Physicians are encouraged to share the IOM physician toolkit for GWG (available at www.nationalacademies.org) with their patients in order to promote proper weight gain during pregnancy.
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